Choosing the appropriate sclerosing concentration for vessel diameter

Dermatologic Surgery

Volumn 36, Issue SUPPL. 2, 2010, Pages 976-981

  Sadick, Neil S ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCEROL; IODINE; MONOETHANOLAMINE OLEATE; MORRHUATE SODIUM; POLIDOCANOL; POLYIODIDE IODINE; SCLERODEX; SCLEROSING AGENT; SODIUM CHLORIDE; TETRADECYL SULFATE SODIUM; UNCLASSIFIED DRUG;

BLOOD VESSEL DIAMETER; DRUG EFFICACY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG USE; FOOD AND DRUG ADMINISTRATION; HIRSUTISM; HUMAN; HYPERPIGMENTATION; MEDICAL DECISION MAKING; MOBILIZATION; NONHUMAN; PATIENT INFORMATION; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; REVIEW; SAPHENOUS VEIN; SCLEROTHERAPY; SKIN BRUISING; SKIN DISCOLORATION; SWELLING; TREATMENT INDICATION; TREATMENT OUTCOME; ULCER; VARICOSIS;

AFTERCARE; DECISION MAKING; DETERGENTS; HUMANS; IRRITANTS; MICROBUBBLES; SCLEROSING SOLUTIONS; SCLEROTHERAPY; TELANGIECTASIS; VARICOSE VEINS;

EID: 77952908709     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2009.01405.x     Document Type: Review

References (21)

1. Sadick NS. Sclerotherapy of varicose veins and telangiectatic leg veins. Minimal sclerosant concentration of hypertonic saline and its relationship to vessel diameter. J Dermatol Surg Oncol 1991 17 : 65 70.
2. Norris MJ, Carlin MC, Ratz JL. Treatment of essential telangiectasia: effects of increasing concentrations of polidocanol. J Am Acad Dermatol 1989 20 : 643 649.
3. Moil W, Furukawa H, Sasaki S, et al. Evaluation of the sclerotherapeutic efficacy of ethanol, polidocanol and OK-432 using an in vitro model. Dermatol Surg 2007 33 : 1452 1459.
4. Goldman MP. Treatment of varicose and telangiectatic leg veins: double-blind prospective comparative trial between aethoxyskerol and sotradecol. Dermatol Surg 2002 28 : 52 5.
5. Weiss RA. Polidocanol: the perfect "solution". Editorial. J Dermatol Surg Oncol 1994 20 : 465.
6. Shimada H, Makuuchi H, Machimura T, et al. Studies on vascular endothelial cell damage by polidocanol in relation to concentration, ethylene-oxide chain length and exposure time. Dig Endosc 1998 10 : 14 21.
7. Conrad P, Malouf GM, Stacey MC. The Australian polidocanol (aethoxysklerol) study: results at 1 year. Phlebology 1994 9 : 17 20.
8. McCoy S, Evans A, Spurrier N. Sclerotherapy for leg telangiectasia-a blinded comparative trial of polidocanol and hypertonic saline. Dermatol Surg 1999 25 : 381 386.
9. Kobayashi S, Crooks S, Eckmann DM. Dose- and time dependent liquid sclerosant effects on endothelial cell death. Dermatol Surg 2006 32 : 1444 1452.
10. Almeida JI, Raines JK. FDA-approved sodium tetradecyl sulfate (STS) versus compounded STS for venous sclerotherapy. Dermatol Surg 2007 33 : 1037 1044.
11. Carlin MC, Ratz JL. Treatment of telangiectasia: comparison of sclerosing agents. J Dermatol Surg Oncol 1987 13 : 1181 1184.
12. Martin DE, Goldman MP. A comparison of sclerosing agents: clinical and histologic effects of intravascular sodium tetradecyl sulfate and chromated glycerin in the dorsal rabbit ear vein. J Dermatol Surg Oncol 1990 16 : 18 22.
13. Leach BC, Goldman MP. Comparative trial between sodium tetradecyl sulfate and glycerin in the treatment of telangiectatic leg veins. Dermatol Surg 2003 29 : 612 615.
14. Redondo P, Cabrera J. Microfoam sclerotherapy. Semin Cutan Med Surg 2005 24 : 175 183.
15. Cabrera J, Cabrera J Jr., Garcia-Olmedo A. Treatment of varicose long saphenous veins with sclerosant in microfoam form: long term outcomes. Int Angiol 2001 20 : 322 329.
16. Frullini A. Sclerosing foam with polidocanol or sodium tetradecyl sulfate in the treatment of superficial venous insufficiency. Scope Phlebol Lymphol 2001 3/4 : 289 292.
17. Kern P, Ramelet AA, Wutschert R, et al. Single-blind randomized study comparing chromated glycerin, polidocanol solution and polidocanol foam for treatment of telangiectatic leg veins. Dermatol Surg 2004 30 : 367 372.
18. Breu FX. Guggenbichler St. European Consensus Meeting on Foam Sclerotherapy, April, 4-6, 2003, Tegernsee, Germany. Dermatol Surg 2004 30 : 709 717.
19. Sadick NS. Foam sclerotherapy. Cosmet Dermatol 2002 15 : 51 3.
20. Exkmann DM, Kobayashi S, Li M. Microvascular embolization following polidocanol microfoam sclerosant administration. Dermatol Surg 2005 31 : 636 643.
21. Regan JD, Gibson KD, Ferris B, et al. Safety of proprietary sclerosant Microfoam for saphenous incompetence in patients with R-to-L shunt: interim report. J Vasc Interv Radiol 2008 19 (Suppl) : S35. Abstract.